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Available online 8 May 2015Adding a single O-GlcNAc moiety to a Ser/Thr molecule of a protein by O-GlcNAc transferase and transiently re-
moving it by O-GlcNAcase is referred to as O-GlcNAc cycling (or O-GlcNAcylation). This O-GlcNAcmodiﬁcation is
sensitive to nutrient availability and also shows cross talk with phosphorylation signaling, affecting downstream
targets. A mouse model systemwas developed and evaluated to show genome wide transcriptional changes as-
sociatedwith disruption of O-GlcNAc cycling. Mouse embryonic ﬁbroblast cells derived fromO-GlcNAcase (Oga)
knock out (KO), heterozygous (Het) andwild type (WT) embryos were used for an Affymetrix basedmicroarray.
Results are deposited inGEOdatasetGSE52721. Data reveals thatOgaKOMEFs had 2534 transcripts differentially
expressed at 1.5 fold level while Oga heterozygous MEFs had 959 transcripts changed compared to WT MEFs.
There were 1835 transcripts differentially expressed at 1.5 fold Het versusWT comparison group. Gene ontology
analysis indicated differentially expressed genes enriched inmetabolic, growth, and cell proliferation categories.
© 2015 The Author. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).5) heterozygous mouse
etic background C57BL/6)
e (B6129-Tgn(MMTV-cre).
EF cells at E12.5 for the study.
EF cell Oga KO,
(both Oga alleles present)
ived from Oga KO,1. Direct link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE52721.2. Experimental design, materials and methods
2.1. MEF cells
Transgenic mice bearing an O-GlcNAcase heterozygous allele were
developed from Oga ﬂoxed mice cross breeding with Cre mice as. This is an open access article underdescribed in [1]. The resultant Oga heterozygous mice were cross bred
to derive mouse embryonic ﬁbroblast (MEF) cells for this study.
MEF cells were collected at embryonic day 12.5 following the protocol
from the Fred Hutchinson Cancer Center (www.fhcrc.org/science/labs/
fero/Protocols/MEFs.html). Cells were cultured in DMEM media added
with 10% FBS and 100 U/ml penicillin and 100 μg/ml streptomycin.
Gene and protein expression patterns of wild type, heterozygous and
KO MEFs were evaluated using PCR and Western blotting. Genotypes
were conﬁrmed by PCR and increased O-GlcNAcmodiﬁcation in proteins
observed in Oga KO and heterozygous cell lines compared to wild type
reﬂecting Oga deletion (Fig. 1).
2.2. RNA extraction and microarray
Female MEF cells fromwild type (WT), Oga heterozygous (Het) and
Oga knock out (KO) genotypes, collected from a single litter were used
for the microarray study. RNA extracted using TRIzol reagent
(Invitrogen) according to the manufacturer's protocol. Total RNA
digested with RNAse free DNAse I, followed by column puriﬁcation
(Qiagen Inc., CA). RNA quantiﬁed by NanoDrop and quality assessed by
Bioanalyzer trace (Agilent Technologies, CA) and samples with RNA in-
tegrity number (RIN #) above 7.9 the were selected for the assay.
The total RNA from each sample (5 μg) was used for cDNA synthesis
and biotin labeling, in three technical replicates for each group. Samples
were processed using Affymetrix kits according to themanufacturer's in-
structions at the NIDDK Genomic Core facility. Samples were hybridizedthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Fig. 1.Genotypes of the cell lines showing PCR bands forWT, Het and KO alleles (A) and a
Western immunoblot showing O-GlcNAcylated protein expression (B), probed by
anti O-GlcNAc antibody (RL2— anti rabbit) followed by green ﬂuorescence secondary
antibody. Loading controls were shown by actin expression, detected by anti-actin
followed by red ﬂuorescence tagged secondary antibody (anti mouse).
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were washed, and stained using FS450 ﬂuidic stations (protocol FS450-
0004) using reagents from HWS kits (Affymetrix Inc.). The arrays were
scanned using a 3000G Affymetrix scanner operated by GeneChip Oper-
ating Software (GCOS), which generated 9 data ﬁles. Data were normal-
ized using the MAS5 algorithm.
2.3. Data analysis
Image ﬁles (.cel) were further analyzed by Partek software (Partek
Inc., St. Louis, MO) to identify differentially expressed genes. QualityFig. 2. Quality assessment of microarray data. (A) Boxplot, (B) PCA plot and (C) volcano
comparison Total genes 
1.5 FC (2FC)
Unique 
transcripts
KO Vs WT 2534(839) 1790 (619)
HET Vs WT 959(111) 686 (82)
HET Vs KO 1835(474) 1344(364)
A
Fig. 3. (A) Total, unique and unknown transcripts associated with each comparison. (B) Venn d
1.5 fold level.control features indicated all arrays were good and signal intensity
box plots are shown in Fig. 2A. Principle component analysis (PCA)
shows 66% of data could be described by genotype differences and
well separated into 3 groups (Fig. 2B). The volcano plot from KO against
WT comparison shows a large number of genes signiﬁcantly affected
even at 2 fold level (Fig. 2C). Data statistically analyzed using Partek
ANOVA and Oga Het and KO groups were compared with WT and also
with each other, and considered signiﬁcant at p b 0.05 level. Gene lists
were generated for 1.5 fold or 2 fold differentially expressed transcripts
with multiple test correction for false discovery ratio (FDR) set at 0.05
level. Five transcripts interrogated Oga (Mgea5) gene were signiﬁcantly
reduced in KO group compared to WT and intermediate levels were
seen in Het group. A total of 2534 transcripts from the KOgroup showed
1.5 fold change compared to WT with 1404 reduced transcripts and
1130 increased. Table in Fig. 3A shows the number of transcripts passed
at 1.5 fold or (2 fold) level and unique or unknown transcripts for each
comparison. The distribution of 1.5 fold signiﬁcant transcripts in each
comparison category is shown in a Venndiagram(Fig. 3B). These results
indicate that deletion of both Oga alleles changed the gene expression
signiﬁcantly while partial deletion (Het) had limited effects on gene
expression. Similar effect was also reﬂected by the other biological
parameters observed in live animals [1]. A heat map from hierarchical
clustering of differentially expressed genes in KO and WT is shown in
Fig. 4 (y axis sample type, x axis genes, blue reduced, and red increased
gene expression). The cluster map shows single row for each sample
and 3 replicates from each genotypeswere very similar and tightly clus-
tered (raw colors). Columns of gene clusters in the heterozygous group
(middle) have shownhigher similaritywithWTwhile few gene clusters
are similar to the KO group. Gene enrichment analysis was performed
using a Gene Ontology (GO) database (MM 2012-11-19 release) to
understand the biological effects. The group of 2534 transcripts (KO vs
WT) showed the highest enrichment in genes associated withmetabolic,
and proliferation processes (Fig. 4B). Het group compared to WT (959)plot showing signiﬁcantly affected genes (solid lines at p b 0.05 and 2 fold level).
unknown
147 (36)
183 (22)
83(13)
B
iagram showing distribution of differentially expressed transcripts in all 3 comparisons at
Fig. 4. (A) Hierarchical clustering of KO vsWT transcripts change at 1.5 fold (p N 0.05) showing 4 clusters (x axis) and GOenrichment categories in differentially expressed genes (1.5 fold)
in (B) KO against WT and (C) Het against WT comparisons.
Table 1
Top 10 highly enriched pathways in 2 fold differentially expressed genes in KO vs WT group as analyzed by Genomatix software.
Pathway p value # of genes (observed) # of genes (expected) # of genes (total)
Spleen tyrosine kinase 4.88E−07 20 5.62506 102
Integrin 1.95E−06 26 9.48540 172
Toll like receptor 6.11E−06 23 8.27215 150
Interleukin 2 7.86E−05 19 7.16920 130
Guanine nucleotide exchange factor VAV 2.66E−04 15 5.40447 98
Angiotensin 2.98E−04 15 5.45962 99
Granulocyte colony stimulating factor receptor 4.20E−04 11 3.36401 61
Nuclear factor of activated t cells, cytoplasmic, calcineurin dependent 5.62E−04 16 6.39713 116
Chemokine (C–C motif) ligand 2 6.38E−04 12 4.08093 74
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The same data set is analyzed with Genomatix (Germany) software
using gene ranker analysis also showing similar categories while
highest probability in enrichment is associated with innate immunity
genes (data not shown). Pathway analysis conducted using 839
(2 fold change) transcripts from KO versus WT comparison using GePS
(Genomatix) and the highest 10 pathways listed are shown in Table 1.
The highest number of genes are associated with the Integrin pathway
and shown in Fig. 5.
3. Discussion
O-GlcNAc modiﬁcation effects global cellular functions and
details are emerging. The lack of a mammalian model system limits
the understanding of O-GlcNAc signaling. Mouse Ogt deletion is embry-
onic lethal [3]. Deletion of the Oga enzyme which removes O-GlcNAcFig. 5. Genes associated with Integrin pathwamodiﬁcation has also shown about 89% neonatal lethality in mice [1,2].
MEFs isolated from Oga KO, Het and WT embryos were used for the mi-
croarray to facilitate the understanding of global effects. Oga deletion in
MEF cells is conﬁrmed by gDNA PCR and as a result increased O-GlcNAc
modiﬁcation were observed in Het and KO cell types compared to WT.
The present data shows O-GlcNAc modiﬁcation affects not only cellular
signaling but also gene expression. Ogt and Oga are known to associate
with the transcriptome machinery [4,5]. Differentially expressed genes
under Oga deletion indicate the effects in multiple cellular functions
such as metabolism, cell proliferation, and growth. Perturbation of O-
GlcNAc cycling affects metabolic pathways crucial for survival and cor-
roborate with the observed neonatal lethal phenotype of Oga KO pups.
Defects of cell proliferation and cytokinesis are also shown through
other scientiﬁc evidence in Oga disrupted cells [2].
Tyrosine kinase pathways are involved in downstream signaling
associated with immunoreceptors in B cell receptors. Many cytokiney shown by genomatix pathway analysis.
33C. Keembiyehetty / Genomics Data 5 (2015) 30–33and immunity associated genes were largely down regulated in KO
MEFs compared to WT. Integrin pathway associated with extracellular
matrix signaling and are signiﬁcantly affected byOgadeletion.Observed
gene regulation inOgaKOgroup could be explainedby lack ofOga activity
directly, or due to increased O-GlcNAc modiﬁcation of proteins. Dysregu-
lation of the O-GlcNAc cycling could also have effects on protein phos-
phorylation (Slowson and Hart [6]), ubiquitin pathway [7], transcription
factor binding, or localization. The present microarray data provide
insight into global effects on multiple cellular functions associated with
disruption of O-GlcNAc modiﬁcation.
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